Caroline Heap
About Caroline Heap
Title and Current Role
Caroline Heap holds the position of Senior Scientist in Scientific Affairs. As a senior scientist, she is responsible for overseeing and guiding various scientific projects, ensuring they meet the standards and goals of her department. Her role encompasses collaboration with other scientists, driving research initiatives, and contributing to the scientific community through publications and presentations.
Education and Expertise
Caroline Heap has earned a PhD, signifying a high level of expertise in her field. She has extensive knowledge and experience, particularly in the areas of immunologic factors, neoadjuvant chemoimmunotherapy, and cancer research. Her specialization includes the study of NK cell ADCC assays, comprehensive genomic profiling, and the landscape of TIGIT and PD-L1 co-expression in solid tumors.
Published Research
Caroline Heap has published research on key topics within oncology. One of her notable publications focuses on the immunologic factors associated with differential response to neoadjuvant chemoimmunotherapy in triple negative breast cancer. Through her research, she contributes valuable insights to the scientific community and advances the understanding of cancer treatments.
Research and Presentations
Caroline Heap has conducted and presented research on various critical aspects of cancer treatment. Her presentations have covered NK cell ADCC assays and comprehensive genomic profiling for hematologic malignancies. Additionally, she has studied and shared findings on the enhanced detection of ctDNA molecular response for immunotherapy-treated non-small cell lung cancer and spatial transcriptomic studies of the tumor microenvironment in head and neck squamous cell carcinoma (HNSCC).
Analytical Performance and Liquid Biopsy
Caroline Heap has expertise in the analytical performance validation for liquid biopsy assays. She has worked on the pre-analytical characterization of cell-free DNA for liquid biopsy in solid tumors. Her research in this area seeks to improve the accuracy and efficacy of liquid biopsy techniques, which are pivotal for non-invasive cancer diagnostics and monitoring.